# Physionic Podcast Videos and Summaries / Transcripts **URL:** \ **Category:** General\ **Created:** [August 29, 2024, 12:13am UTC](https://www.rapamycin.news/t/physionic-podcast-videos-and-summaries-transcripts/15904 "2024-08-29T00:13:37Z")\ **Posts on this page:** 1\ **Showing post:** 129
**Author:** ![RapAdmin](https://www.rapamycin.news/user_avatar/www.rapamycin.news/rapadmin/32/377_2.png) [@RapAdmin](https://www.rapamycin.news/u/RapAdmin)\ **Post date:** [September 18, 2026, 4:11am UTC](https://www.rapamycin.news/t/physionic-podcast-videos-and-summaries-transcripts/15904/129 "2026-09-18T04:11:22Z")
# Supplementing Serine to fix Stress and Insulin Resistance! [![](https://img.youtube.com/vi/_xEHCe1MMgc/maxresdefault.jpg "Supplementing Serine to fix Stress and Insulin Resistance!") ](https://www.youtube.com/watch?v=_xEHCe1MMgc) **Presenter:** Nicholas Verhoeven, PhD (Physionic) ## I. Executive Summary Epidemiological cohorts and clinical human challenge paradigms consistently associate chronic severe psychological stress—specifically post-traumatic stress disorder (PTSD)—with an elevated incidence of metabolic syndrome, insulin resistance, and incident type 2 diabetes (T2D). Prospective longitudinal analysis from the [Nurses’ Health Study II (Roberts et al., JAMA Psychiatry 2015)](https://pubmed.ncbi.nlm.nih.gov/25565410/?utm_source=gemini) demonstrated an 80% increased risk of incident T2D in women exhibiting six to seven PTSD symptoms compared to non-trauma-exposed controls, displaying an exposure-response gradient partially mediated by elevated body mass index (BMI) and psychotropic medication use. Acute human crossover experiments exposing individuals with PTSD to personalized trauma scripts during an oral glucose tolerance test demonstrate acute postprandial hyperinsulinemia and delayed glucose clearance, confirming that psychological distress directly impairs acute glycemic regulation ([Kuehl et al., Neuropsychobiology 2010](https://pubmed.ncbi.nlm.nih.gov/20665427/?utm_source=gemini)). Preclinical mechanistic investigations demonstrate a direct neuro-metabolic circuit linking chronic emotional stress to peripheral glycemic decompensation ([He et al., Cell Metabolism 2026](https://doi.org/10.1016/j.cmet.2026.03.006?utm_source=gemini)). In murine chronic foot-shock models, sustained amygdalar hyperactivation accelerates premature astrocyte cellular senescence. These senescent astrocytes suppress hexokinase 2 (HK2) expression and downregulate the serine synthesis pathway, drastically decreasing astrocytic export of L-serine. Consequently, adjacent neurons lack the required substrate for conversion into D-serine, an obligate co-agonist for synaptic N-methyl-D-aspartate (NMDA) receptors. Hypofunctional NMDA receptor signaling within the central amygdala alters descending polysynaptic autonomic outflow to the pancreas, shifting innervation toward sympathetic (adrenergic) dominance while suppressing parasympathetic (cholinergic) tone, thereby blunting glucose-stimulated insulin secretion and promoting peripheral insulin resistance. Translational claims proposing over-the-counter oral serine supplementation as a panacea for routine psychological stress or insulin resistance exhibit substantial translational gaps. In animal models, normal glucose handling was restored via intracerebroventricular L-serine infusions or systemic senolytic administration (dasatinib plus quercetin). In humans, a pilot double-blind crossover RCT utilizing oral D-serine at 30 mg/kg/day demonstrated preliminary psychiatric symptom reduction in chronic PTSD ([Heresco-Levy et al., Int J Neuropsychopharmacol 2009](https://pubmed.ncbi.nlm.nih.gov/19366490/?utm_source=gemini)), but did not assess glycemic or insulin sensitivity endpoints. Furthermore, clinical trials investigating serine supplementation in non-stressed metabolic populations fail to demonstrate glycemic improvements. Consequently, while neuro-glial senescence represents a compelling mechanism, oral serine therapy for stress-induced insulin resistance remains unvalidated in human clinical practice. ## II. Insight Bullets - **Epidemiological PTSD-Diabetes Gradient:** Longitudinal data from the Nurses’ Health Study II (nearly 50,000 women over 22 years) demonstrated an 80% higher incidence of type 2 diabetes (HR 1.8, 95% CI 1.5–2.1) in individuals exhibiting 6 to 7 PTSD symptoms relative to unexposed controls ([Roberts et al., JAMA Psychiatry 2015](https://pubmed.ncbi.nlm.nih.gov/25565410/?utm_source=gemini)). - **Metabolic and Behavioral Mediation:** Statistical adjustment indicates that roughly half of the elevated diabetes risk in PTSD cohorts is mediated by secondary lifestyle factors, notably elevated BMI and antidepressant pharmacotherapy. - **Discordant Twin Studies:** Prospective analysis of the Vietnam Era Twin Registry revealed that while PTSD was associated with a 40% increased diabetes risk, the association attenuated and became non-significant when comparing twin pairs discordant for PTSD, highlighting shared familial, environmental, or genetic vulnerabilities. - **Acute Stress-Induced Glucoregulatory Impairment:** Acute psychological stress induced by trauma-script exposure during an oral glucose tolerance test (OGTT) in PTSD patients significantly elevates both postprandial blood glucose and circulating insulin, confirming acute whole-body insulin resistance ([Kuehl et al., Neuropsychobiology 2010](https://pubmed.ncbi.nlm.nih.gov/20665427/?utm_source=gemini)). - **Amygdala Astrocyte Senescence Trigger:** Chronic severe psychological stress drives localized premature senescence specifically within astrocytes of the amygdala, altering brain support cell architecture ([He et al., Cell Metabolism 2026](https://doi.org/10.1016/j.cmet.2026.03.006?utm_source=gemini)). - **Astrocytic Glycolytic Arrest via HK2 Suppression:** Senescent astrocytes in the amygdala downregulate hexokinase 2 (HK2), arresting early glycolysis and depleting 3-phosphoglycerate, the primary precursor for the de novo serine synthesis pathway. - **Astrocyte-to-Neuron Serine Shuttling Deficit:** Astrocytes synthesize L-serine and shuttle it to adjacent neurons; stress-induced astrocytic senescence halts this transfer, depleting the neuronal substrate pool. - **Neuronal Serine Racemase Failure:** Amygdalar neurons rely on imported astrocytic L-serine to generate D-serine via serine racemase; chronic stress severely reduces neuronal D-serine concentrations. - **Synaptic NMDAR Hypofunction:** D-serine serves as an essential endogenous co-agonist at the glycine modulatory site of synaptic N-methyl-D-aspartate (NMDA) receptors; D-serine depletion impairs glutamatergic synaptic transmission and neuronal complexity within the amygdala. - **Autonomous Polysynaptic Circuitry:** Polysynaptic retrograde viral tracing identifies a functional circuit originating in central amygdala neurons that innervates the endocrine pancreas via autonomic pathways. - **Autonomic Splanchnic Skewing:** Stress-induced amygdala disinhibition shifts pancreatic innervation into sympathetic (adrenergic) hyperactivation while withdrawing parasympathetic (vagal/cholinergic) tone. - **Pancreatic Islet Dysregulation:** Dominant sympathetic signaling directly blunts first-phase glucose-stimulated insulin secretion from pancreatic beta cells while concurrently stimulating hepatic gluconeogenesis, producing peripheral hyperglycemia. - **Intracerebroventricular L-Serine Rescue in Rodents:** Preclinical direct intracerebroventricular (ICV) infusion of L-serine (9 mg/kg/day) bypassed the astrocytic glycolytic block, restored neuronal D-serine synthesis, and normalized systemic oral glucose tolerance in stressed mice ([He et al., Cell Metabolism 2026](https://doi.org/10.1016/j.cmet.2026.03.006?utm_source=gemini)). - **Glial Senolytic Clearance:** Pharmacological administration of senolytics (dasatinib 5 mg/kg + quercetin 50 mg/kg) successfully cleared senescent astrocytes in murine amygdalae, reducing elevated glucose tolerance area-under-the-curve (AUC) by ~50% back to baseline levels ([He et al., Cell Metabolism 2026](https://doi.org/10.1016/j.cmet.2026.03.006?utm_source=gemini)). - **Amygdala-Liver Axis Corroboration:** Parallel neuro-metabolic investigations confirm that stress-activated medial amygdala neurons project to the ventromedial hypothalamus and polysynaptically activate hepatic sympathetic outflow, driving acute hepatic gluconeogenesis independent of adrenal hormones. - **Human Pharmacological Glycemic Modulation:** Clinical management of PTSD with conventional psychiatric pharmacotherapy produces glycemic reductions selectively in psychiatric treatment responders, whereas treatment-refractory patients show persistent hyperglycemia. - **Human D-Serine Pilot RCT:** In a double-blind, placebo-controlled crossover trial of 22 chronic PTSD outpatients, adjuvant oral D-serine (30 mg/kg/day for 6 weeks) significantly reduced Hamilton Anxiety and Mississippi PTSD scores ([Heresco-Levy et al., Int J Neuropsychopharmacol 2009](https://pubmed.ncbi.nlm.nih.gov/19366490/?utm_source=gemini)). - **Absence of Glycemic Endpoints in Human Trials:** The [Heresco-Levy et al. (2009)](https://pubmed.ncbi.nlm.nih.gov/19366490/?utm_source=gemini) clinical trial focused exclusively on psychometric rating scales, collecting zero oral glucose tolerance, fasting insulin, or HbA1c data. - **Null Glycemic Effects in Non-Stressed Populations:** Human RCTs evaluating oral L-serine or D-serine supplementation in metabolic cohorts lacking severe psychiatric trauma report zero statistically significant improvements in fasting blood glucose or peripheral insulin sensitivity. - **Blood-Brain Barrier (BBB) Pharmacokinetics:** Systemically ingested oral L-serine undergoes hepatic first-pass metabolism and competes with other neutral amino acids at the ASC and LAT1 blood-brain barrier transport systems, leaving its capacity to replicate ICV central amygdalar concentrations highly uncertain. - **D-Serine vs. L-Serine Enantiomer Dissociation:** L-serine serves as a general metabolic building block and precursor, whereas D-serine acts specifically as an active neuroactive NMDAR co-agonist; animal models of stress utilize L-serine centrally, whereas human psychiatric trials test oral D-serine. - **Nephrotoxicity Signals with High-Dose D-Serine:** While oral D-serine at 30 mg/kg/day demonstrated a 6-week safety profile in pilot psychiatric trials, high experimental doses in rodents induce selective necrosis of the straight segment (S3) of renal proximal tubules via D-amino acid oxidase (DAAO) oxidation products. - **Diagnostic Boundary Conflation:** Extrapolating extreme trauma neurobiology (severe PTSD, repetitive physical foot shock) to common daily psychosocial stressors (occupational workload, academic pressure) represents an unverified diagnostic extrapolation. ## IV. Actionable Protocol (Prioritized) ### High Confidence Tier (Level A/B Evidence) - **Objective Metabolic Surveillance in Severe Trauma/PTSD:** Clinicians managing patients with chronic PTSD, acute psychological trauma, or severe chronic distress must implement annual screening for metabolic dysfunction: obtain fasting glucose, fasting insulin (calculating HOMA-IR), and HbA1c. Elevated psychiatric symptom severity warrants heightened surveillance for new-onset type 2 diabetes ([Roberts et al., JAMA Psychiatry 2015](https://pubmed.ncbi.nlm.nih.gov/25565410/?utm_source=gemini)). - **First-Line Trauma Intervention to Mitigate Splanchnic Drive:** Deploy guideline-directed evidence-based psychiatric interventions for PTSD—including trauma-focused Cognitive Behavioral Therapy (CBT), Eye Movement Desensitization and Reprocessing (EMDR), and approved pharmacological agents (sertraline, paroxetine). Successful psychological remission is clinically associated with downstream attenuation of hypercortisolemia, sympathetic tone, and secondary hyperglycemia. - **Autonomic Nervous System Counter-Conditioning:** Combat stress-induced sympathetic overdrive to visceral organs by scheduling structured parasympathetic-activating exercise: 150 to 300 minutes per week of Zone 2 aerobic training, combined with daily slow-paced diaphragmatic breathing (0.1 Hz / 6 breaths per minute) to enhance cardiovagal tone and peripheral glucose uptake independent of insulin. - **Target Traditional Secondary Mediators (Diet and Weight):** Because increased BMI accounts for nearly half of the statistical diabetes risk in chronic stress populations, implement structured, whole-food nutritional regimens (e.g., Mediterranean dietary pattern) designed to prevent hypercaloric stress-eating and visceral adipose accumulation. ### Experimental Tier (Level C/D Evidence, High Safety Margin) - **Adjunctive Oral L-Serine Supplementation (Exploratory):** Patients with high chronic distress and borderline insulin resistance wishing to evaluate the preclinical serine hypothesis may trial oral dietary L-serine at conservative nutritional doses (5 to 10 g/day divided with meals). Monitor baseline and 12-week fasting glucose, fasting insulin, and comprehensive metabolic panels. - **Oral D-Serine Under Specialized Psychiatric Protocol:** For chronic refractory PTSD, oral D-serine supplementation (at the trial-evaluated dose of 30 mg/kg/day, roughly 2.0 to 2.5 g/day for an average adult) represents an experimental adjunct to standard psychopharmacology ([Heresco-Levy et al., Int J Neuropsychopharmacol 2009](https://pubmed.ncbi.nlm.nih.gov/19366490/?utm_source=gemini)). Routine surveillance of serum creatinine, blood urea nitrogen (BUN), and urinalysis is mandatory to evaluate potential renal proximal tubule toxicity. - **Support Astrocytic Endogenous Serine Synthesis:** Ensure sufficient intake of essential cofactor micronutrients involved in one-carbon metabolism, DNA methylation, and transsulfuration pathways—including pyridoxal 5’-phosphate (vitamin B6), methylcobalamin (vitamin B12), and active folate (5-MTHF)—to sustain physiological endogenous serine-glycine flux. ### Red Flag Zone (Debunked or Lacking Safety Data) - **Relying on Oral Serine as a Primary Treatment for Type 2 Diabetes:** \* Fatal Translational Assumption.\* No randomized clinical trial demonstrates that oral serine monotherapy reverses clinical type 2 diabetes or normalizes insulin resistance in humans. In the seminal animal study ([He et al., Cell Metabolism 2026](https://doi.org/10.1016/j.cmet.2026.03.006?utm_source=gemini)), glycemic rescue required direct _intracerebroventricular brain micro-infusions_ (ICV), which cannot be extrapolated to oral dietary ingestion. - **Self-Administering Unsupervised Senolytics for Stress or Glycemia:** \* High Toxicity / Safety Data Absent.\* Although dasatinib plus quercetin (D+Q) cleared senescent amygdalar astrocytes and normalized glucose clearance in rodents, off-label administration of oncology-grade tyrosine kinase inhibitors (dasatinib) in non-oncologic, stressed human populations carries life-threatening risks: myelosuppression, pleural effusions, hemorrhagic diathesis, and severe immunosuppression. - **High-Dose D-Serine Ingestion Without Renal Surveillance:** \* Renal Tubular Toxicity Risk.\* Ingesting unmonitored megadoses of D-serine (\>60–120 mg/kg/day) carries established preclinical risks of DAAO-mediated selective tubular necrosis. D-serine must never be confused with benign nutritional L-serine. - **Equating Everyday Work Stress Directly with the Neurobiology of PTSD:** \* Misleading Extrapolation.\* Extrapolating the severe amygdalar astrocyte senescence, neuronal decay, and autonomic collapse observed in rodent inescapable foot-shock models or severe chronic human PTSD to transient everyday stressors (e.g., job deadlines, academic examinations) is mechanistically invalid and unverified. Produced by Gemini 2.5 Pro --- _[View the full topic](https://www.rapamycin.news/t/physionic-podcast-videos-and-summaries-transcripts/15904)._